DeVinney Erick Wayne 4

What Happened Erick Wayne DeVinney, Chief Innovation Officer of Axogen, reported that restricted stock units (RSUs) vested on March 16, 2026 and converted into common shares (reported as derivative exercises). The filing shows conversion entries totaling 35,876 shares (acquired at $0.00 per share). From that vesting, 2,870 shares were withheld to satisfy tax obligations (value $94,251) and 5,221 shares were sold in an open‑market transaction at $32.84 per share for proceeds of $171,458. The remaining shares from this vesting were retained by the reporting person.

Key Details

• Transaction date: March 16, 2026; Form 4 filed March 18, 2026 (timely).
• Conversion entries (code M): multiple RSU conversions totaling 35,876 shares @ $0.00.
• Tax withholding (code F): 2,870 shares withheld @ $32.84 = $94,251 (net settlement, not an open‑market sale).
• Open‑market sale (code S): 5,221 shares sold @ $32.84 = $171,458.
• Net shares retained from this vesting (35,876 converted less 2,870 withheld and 5,221 sold): 27,785 shares.
• Shares owned after the transaction (total beneficial ownership) are not disclosed in the filing.
• Footnotes: RSUs vested and convert 1:1 to common stock; withholding was used to satisfy tax remittance; vesting schedule described in notes (annual vesting with prior tranches vesting in prior years).

Context

• These entries reflect RSU vesting and a common net‑settlement pattern: RSUs convert to shares (no cash exercise price), some shares are withheld for taxes, and a portion sold in the open market to cover tax or liquidity needs.
• This is a routine insider vesting and partial sale for tax/monetization purposes, not a conventional purchase (purchases typically signal new insider accumulation).
• No indication in the filing of a 10b5‑1 plan, gift, or other special arrangement; the filing appears timely.